Detalhe da pesquisa
1.
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Gynecol Oncol
; 176: 162-172, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556934
2.
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.
Int J Cancer
; 148(2): 469-480, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038264
3.
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Cancer Res
; 81(7): 1681-1694, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33441310
4.
Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.
Cells
; 9(6)2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32512818
5.
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.
Cancer Res
; 78(10): 2691-2704, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29487201
6.
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Eur Urol
; 73(6): 949-960, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29544736
7.
Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.
Oncotarget
; 8(16): 25928-25941, 2017 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28460430